此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Adjunctive Topical Melatonin Gel in Non-Surgical Periodontal Therapy for Periodontitis

2026年5月18日 更新者:Ishma Binte Saeed、Liaquat College of Medicine and Dentistry

Evaluation of Clinical Outcomes of Adjunctive Topical Melatonin Gel in Non-Surgical Periodontal Therapy: A Randomized Placebo-Controlled Trial in Karachi

The goal of this clinical trial is to evaluate the clinical effectiveness of adjunctive topical melatonin gel when used with non-surgical periodontal therapy (NSPT) in adult patients with periodontitis. This study includes systemically healthy or medically controlled patients aged 18-45 years who are diagnosed with periodontitis and attend the Department of Periodontology at Liaquat College of Medicine & Dentistry, Karachi.

The main questions it aims to answer are:

  • Does adjunctive topical 5% melatonin gel improve clinical attachment level (CAL) compared to placebo after NSPT?
  • Does adjunctive topical 5% melatonin gel improve plaque index (PI), gingival index (GI), and periodontal pocket depth (PPD) compared to placebo after NSPT? Researchers will compare patients receiving NSPT with topical melatonin gel to patients receiving NSPT with placebo gel to determine whether melatonin provides additional clinical benefits in periodontal therapy.

Participants will:

  • Undergo baseline periodontal examination, including assessment of plaque index, gingival index, periodontal pocket depth, and clinical attachment level.
  • Receive non-surgical periodontal therapy (scaling and root planing).
  • Be randomly assigned to receive either 5% topical melatonin gel or placebo gel applied intra-pocket.
  • Attend follow-up visits for gel application and monitoring.
  • Undergo reassessment of clinical periodontal parameters after three months.
  • Be monitored for any adverse effects during the study period. This study is a randomized, double-blind, placebo-controlled clinical trial evaluating the role of topical melatonin gel as an adjunct to conventional non-surgical periodontal therapy in improving periodontal clinical outcomes.

研究概览

详细说明

Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth and is one of the leading causes of tooth loss worldwide. The disease is initiated by pathogenic bacterial biofilm and progresses through a complex host inflammatory response that results in destruction of the periodontal ligament, alveolar bone loss, periodontal pocket formation, and clinical attachment loss. In Pakistan, periodontitis has a high prevalence and represents a significant oral health burden affecting quality of life and overall health.

Non-surgical periodontal therapy (NSPT), consisting primarily of scaling and root planing, is considered the gold standard treatment for periodontitis. NSPT effectively reduces microbial load and improves periodontal clinical parameters, including plaque index (PI), gingival index (GI), probing pocket depth (PPD), and clinical attachment level (CAL). However, despite the effectiveness of mechanical debridement, complete resolution of inflammation and periodontal tissue regeneration may not always be achieved, leading researchers to investigate adjunctive therapeutic approaches.

Melatonin is a naturally occurring hormone mainly secreted by the pineal gland and is known for regulating circadian rhythm. In addition to its physiologic role, melatonin possesses antioxidant, anti-inflammatory, immunomodulatory, and bone-regenerative properties. Experimental and clinical studies have suggested that melatonin may reduce oxidative stress, regulate inflammatory mediators, inhibit tissue destruction, and promote osteoblastic activity and collagen formation. These biologic effects indicate its potential usefulness as an adjunctive agent in periodontal therapy.

Previous international studies have demonstrated promising results with topical melatonin application in periodontal treatment, showing improvements in inflammatory parameters and periodontal healing. However, there is limited evidence regarding its clinical effectiveness in the Pakistani population, and no randomized placebo-controlled clinical trial has been conducted locally to evaluate its adjunctive role with NSPT.

This study is designed as a randomized, double-blind, placebo-controlled clinical trial to assess the clinical outcomes of adjunctive topical melatonin gel in patients undergoing non-surgical periodontal therapy. A total of 30 patients diagnosed with periodontitis will be recruited from the Department of Periodontology at Liaquat College of Medicine & Dentistry, Karachi. Eligible participants will include adults aged 18-45 years who are systemically healthy or medically controlled and diagnosed with periodontitis with clinical attachment loss between 3-4 mm.

Participants will be randomly allocated into two groups. The experimental group will receive NSPT followed by intra-pocket application of 5% topical melatonin gel, while the control group will receive NSPT followed by placebo gel application. Both gels will be similar in appearance to maintain blinding. The study will follow a double-blind design in which both participants and the primary investigator assessing outcomes will remain unaware of group allocation.

Clinical periodontal parameters, including Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD), and Clinical Attachment Level (CAL), will be recorded at baseline and reassessed after three months. Participants will also be monitored for adverse effects such as burning sensation, taste alteration, or mucosal irritation throughout the study period.

The primary objective of the study is to compare the clinical effectiveness of adjunctive topical melatonin gel with placebo in improving periodontal clinical outcomes following NSPT. The findings of this study may contribute to the growing evidence regarding host-modulatory therapy in periodontics and help determine whether topical melatonin can serve as a cost-effective adjunctive treatment option in periodontal care within the local population.

研究类型

介入性

注册 (实际的)

30

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Sindh
      • Karachi、Sindh、巴基斯坦、7290
        • Liaquat College of Medicine and Dentistry

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

不

描述

Inclusion Criteria:

  • Patients aged 18-45 years
  • Patients diagnosed with periodontitis with clinical attachment loss (CAL) between 3-4 mm
  • Systemically healthy individuals
  • Patients with controlled systemic diseases (ASA I & II)
  • Patients willing to participate and provide informed consent

Exclusion Criteria:

  • Smokers or tobacco users
  • Pregnant or lactating females
  • Patients with uncontrolled diabetes mellitus (HbA1c >6.5%)
  • Patients who received periodontal therapy within the last 6 months
  • Patients who used antibiotics, anti-inflammatory drugs, sleeping pills, or antioxidant supplements within the last 6 months
  • Individuals working night shifts -Patients with mental illness or neuromuscular disorders-
  • Patients unwilling to participate or unable to comply with follow-up visits

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Test Group
Participants in the experimental group received non-surgical periodontal therapy (scaling and root planing) followed by intrapocket application of 5% topical melatonin gel. The gel was applied weekly during the first month after therapy. Clinical periodontal parameters, including Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD), and Clinical Attachment Level (CAL), were evaluated at baseline and after three months to assess treatment outcomes.
A locally delivered 5% topical melatonin gel applied intra-pocket as an adjunct to non-surgical periodontal therapy (scaling and root planing). The gel was prepared using a standardized gel base and administered weekly during the first month of treatment. Melatonin gel was used to evaluate its potential anti-inflammatory, antioxidant, and periodontal healing effects in patients with periodontitis.
安慰剂比较:Control Group
Participants in the control group received non-surgical periodontal therapy (scaling and root planing) followed by intrapocket application of placebo gel identical in appearance to the melatonin gel but without the active ingredient. The placebo gel was applied weekly during the first month after therapy. Clinical periodontal parameters, including Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD), and Clinical Attachment Level (CAL), were evaluated at baseline and after three months to assess treatment outcomes.
A locally delivered placebo gel applied intrapocketly as an adjunct to non-surgical periodontal therapy (scaling and root planing). The placebo gel contained the same gel base and appearance as the experimental melatonin gel but without the active melatonin ingredient. It was administered weekly during the first month of treatment to serve as a control for comparison of clinical periodontal outcomes.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Probing Pocket Depth (PPD)
大体时间:3 Months
Measured using a UNC-15 periodontal probe in millimeters from baseline to 3 months following non-surgical periodontal therapy.
3 Months
Change in Clinical Attachment Level (CAL)
大体时间:3 Months
Measured using a UNC-15 periodontal probe in millimeters from baseline to 3 months following non-surgical periodontal therapy.
3 Months

次要结果测量

结果测量
措施说明
大体时间
Change in Gingival Index (GI)
大体时间:3 Months
Assessed using standardized gingival inflammation scoring from baseline to 3 months following therapy.
3 Months
Change in Plaque Index (PI)
大体时间:3 Months
Assessed using standardized plaque accumulation scoring from baseline to 3 months following therapy.
3 Months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年11月3日

初级完成 (实际的)

2026年1月5日

研究完成 (实际的)

2026年4月10日

研究注册日期

首次提交

2026年4月29日

首先提交符合 QC 标准的

2026年5月18日

首次发布 (实际的)

2026年5月26日

研究记录更新

最后更新发布 (实际的)

2026年5月26日

上次提交的符合 QC 标准的更新

2026年5月18日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • ASRB/No./09930/MS

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅